Fake News Tests Facebook Ahead of French Vote

Facebook says it has ramped up efforts to curb misinformation, including removing accounts and labeling fake news. But video and images disseminating fake news are increasing faster, alongside delays in accrediting Facebook’s fact-checking partners.

from WSJ.com: US Business http://ift.tt/2oAq88j
via IFTTT

Avaya Files Plan to Slash Debt Load By More Than $4 Billion

Bankrupt telecommunications firm Avaya Inc. has filed a restructuring plan that, if approved by a judge, would cut more than $4 billion in debt from the company’s books.

from WSJ.com: US Business http://ift.tt/2ocNePO
via IFTTT

Apple Gets Permit to Test Autonomous Vehicles in California

Apple secured a permit for autonomous-vehicle testing in California, the clearest sign to date of progress in the company’s efforts to develop self-driving car technology.

from WSJ.com: US Business http://ift.tt/2oIqnOQ
via IFTTT

United Chairman Apologizes Over Passenger's Removal

Nearly a week after police officers violently dragged a passenger off one of its airplanes, United Continental Holdings Inc.’s chairman told the carrier’s employees in a memo that the board is “deeply sorry and upset.”

from WSJ.com: US Business http://ift.tt/2oIDAqX
via IFTTT

Winner of Rights to Prince's Music Feels Shortchanged

Universal Music won the licensing rights to late pop star Prince’s “vault” of unreleased music and other recordings, but people familiar with the matter said the company is concerned it didn’t get what it was promised in its contract.

from WSJ.com: US Business http://ift.tt/2oIuJpk
via IFTTT

REI Founder, a 'Sacrificed Pawn,' Was Rediscovered in Her Old Age

Mary Anderson, founder of outdoor retailer REI, died last month at age 107. Late in life, she was rediscovered for nurturing a tiny cooperative that now has annual sales of more than $2.5 billion and 147 stores.

from WSJ.com: US Business http://ift.tt/2pjThmh
via IFTTT

FDA Rejects Eli Lilly and Incyte Drug

Eli Lilly and Incyte said the U.S. Food and Drug Administration didn’t approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales.

from WSJ.com: US Business http://ift.tt/2pjXM0k
via IFTTT